RSV Diagnostics Market

RSV Diagnostics Market: Outlook

Respiratory Syncytial Virus (RSV) is a respiratory pathogen that can result in causing lower respiratory tract infections prominently among the elderly and the infants. It comprises a considerable disease burden across the globe. Lately, the cases related to RSV are on the rise. To prevent the spread of RSV, early detection is necessary. Hence, the global RSV diagnostics market may gain substantially on this factor between 2020 and 2030.

RSV diagnostics market, on the basis of product can be classified into instruments, molecular diagnostics, optical immunoassays, chromatographic immunoassays, rapid antigen detection kits, and other products. RSV diagnostics are used across diverse end-users such as hospitals, clinics, laboratories, and home care. Currently, no definite treatment or cure is available for RSV. Therefore, early diagnosis is necessary for not letting it spread among others.

This report on the RSV diagnostics market enlightens the stakeholders and CXOs. This report follows the R.O.C.K (Regional Prospects. Overview. Competitive Dimensions. Key Trends) philosophy. This philosophy includes all the significant prospects that are important for the growth of the RSV diagnostics market and helps to gain rock-solid insights.

The information included in this report has been designed after a scrutinized analysis on a variety of factors by an expert team of researchers. The report also offers insights into the COVID-19 impact on the RSV diagnostics market and the prominent threats that the RSV diagnostics market may face between 2020 and 2030.

RSV Diagnostics Market: Competitive Insights

The players in the RSV diagnostics market are involved in intense competition. Manufacturers in the RSV diagnostics market are also involved in expansive research and development activities to develop accurate diagnostic tests that obtain results in a lower period. The players are also focusing largely on molecular testing type as it is gaining popularity as the most preferred mode of testing among a large number of individuals.

Home-care RSV diagnostics are also being developed on a large-scale by the players to adhere to the increasing demand for such kits. A majority of startups and new players are also entering the RSV diagnostics market with modern and more accurate diagnostics kits that seamlessly diagnose RSV effectively. Mergers and acquisitions form an important component for the players in the RSV diagnostics market to cement their position, eventually generating growth.

Some prominent players in the RSV diagnostics market are DiaSorin SPA, Fast-track Diagnostics, Thermo Fisher Scientific Inc., Novartis Diagnostics, Quest Diagnostics, Quidel Corporation, and Hoffmann La Roche Limited.

RSV Facts and Figures

According to the National Institute of Health (NIH), RSV infects about 64 mn individuals and leads to nearly 160000 deaths every year. Each year, approximately 3 mn of the pediatric population is diagnosed with RSV and more than 57000 children die each year due to increased complications. These figures highlight the alarming need for RSV diagnostics.

RSV Diagnostics Market: Recent Developments

RSV diagnostics are recently being used for testing COVID-19 infections among the populace. Various players are also developing diverse diagnostics that test RSV and COVID-19 simultaneously. For instance, Quidel Corporation recently received funding from Biomedical Advanced Research and Development Authority to develop a point-of-care diagnostic assay that diagnoses 4 respiratory viruses such as Influenza A, Influenza B, RSV, and SARS-CoV-2. Such developments may invite magnifying growth for the RSV diagnostics market.

RSV Diagnostics Market: Regional Prospects

North America may emerge as a champion of growth during the forecast period of 2020-2030 due to the rising cases of RSV infections across the region. Asia Pacific may also observe significant growth due to rapidly growing cases of COVID-19 in the region and the use of RSV diagnostics kits in detecting COVID-19. Efforts for increasing healthcare testing for respiratory infections are also bringing great growth opportunities.